Carregant...
Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs
BACKGROUND AND OBJECTIVE: Patients with rheumatic disease taking long-term disease-modifying anti-rheumatic drugs (DMARDs) are expected to have a higher risk of infection due to the alterations in cellular immunity associated with these medications. However, the potential risks associated with these...
Guardat en:
| Publicat a: | Clin Rheumatol |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8164488/ https://ncbi.nlm.nih.gov/pubmed/34052904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-021-05779-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|